Spotted lanternflies blacken a tree-of-heaven trunk at a property along Airport Highway in Toledo, Ohio, Oct. 4, 2024. The ...

Washington — Former President Trump captured the crucial battleground state of Pennsylvania, one of the states projected to deliver him the White House. CBS News projected early Wednesday ...

U.S. Senate candidate David McCormick of Pennsylvania sought a court order that would allow the Republican to challenge provisional ballots en masse in Philadelphia in a race he appears to have ...

As all eyes look to Pennsylvania, voters across the commonwealth went to the polls to cast their ballots Tuesday. With more than one million ballots already sent in by mail, millions more were ...

Donald Trump has picked up 19 electoral votes with the critical Pennsylvania win, the Associated Press reported on Wednesday, Nov. 6 Brian Brant is an Associate Editor, Human Interest at PEOPLE.

To date, more than 2 million people have requested mail-in ballots in Pennsylvania and so far, 71% – over 1.5 million – have returned them. Unlike in most other states – the secretary of ...

Pennsylvania is set to be a decisive state in the 2024 election on Tuesday. Polls open at 7 a.m. ET in Pennsylvania, a “blue wall" state. This year, it's the spot where Harris and Trump met ...

Pennsylvania is arguably the most important individual race in the election, offering both candidates a pathway to the 270 electoral college votes needed to secure the White House. Both the ...

Both Donald J. Trump and Kamala Harris fought hard for Pennsylvania’s 19 electoral votes, dumping more money into the state than any other by far. By Jonathan Weisman Former President Donald J.

See how various groups in Pennsylvania voted for president and U.S. Senate in the 2024 election by reviewing data from the network exit poll conducted by Edison Research. Presidential charts show ...

Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...

Nanoscope Therapeutics, Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degeneration (AMD), today announced ...